SCHEMBL29520169

SCHEMBL29520169

CC1(C)OB(c2ccc3c(c2)ncn3CCO)OC1(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.40
HSD17B10 Q99714 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.37
HDAC1 Q13547 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
LPL P06858 3/20 0.35
LIPG Q9Y5X9 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
F11 P03951 1/20 0.35
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
GFER P55789 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.33
FFAR1 O14842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29520593 0.90 MTNR1A (0.39) IRAK4TDP1LPLLIPGF11
SCHEMBL23638475 0.90 MTNR1A (0.39) IRAK4TDP1LPLLIPGF11
SCHEMBL14250361 0.86 LMNA (0.50) MAPTHSD17B10HDAC1TDP1LPL
SCHEMBL14251023 0.85 NPC1 (0.43) MAPTHSD17B10IRAK4HDAC1TDP1
SCHEMBL17678212 0.85 HDAC1 (0.39) MAPTHSD17B10IRAK4HDAC1TDP1
SCHEMBL17042215 0.85 MEN1 (0.51) MAPTHSD17B10IRAK4TDP1LPL
SCHEMBL15205670 0.84 KDM4E (0.39) MAPTHSD17B10IRAK4TDP1LPL
SCHEMBL2144580 0.83 MTNR1A (0.42) MAPTIRAK4HDAC1NPC1RAB9A
SCHEMBL17678096 0.83 HDAC1 (0.45) MAPTHSD17B10IRAK4HDAC1TDP1
SCHEMBL17678244 0.83 MAPT (0.42) MAPTHSD17B10IRAK4HDAC1LPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063140-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AS HPK1 MODULATOR AND METHODS USING SAME SHENZHEN IONOVA LIFE SCIENCE CO., LTD. (CN) 2022-03-31 WO disclosed